TAURIGA SCIENCES, INC.
company.status.inactiveCIK 1142790fmd_1WA3WH95R14783774BYN24QYDRManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Apr 01, 2010 to Dec 31, 2021, 47 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | – | – | 0 | 0 | 0 | 0 |
| Cost of revenue | – | – | – | 0 | – | – | 0 | 0 | 0 | 0 |
| Gross profit | – | – | – | 0 | – | – | 0 | 0 | 0 | 0 |
| Realized investment gains (losses) | – | – | – | – | 0 | – | (0) | (0) | – | – |
| Research and development | 1 | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | – | – | – | – | – | – | – | – | – | 3 |
| Total operating expenses | 5 | 11 | 9 | 4 | 2 | 2 | 2 | 1 | 2 | 4 |
| Operating income | (5) | (11) | (9) | (4) | (2) | (2) | (2) | (1) | (2) | (3) |
| Interest expense | 0 | 0 | 0 | – | 0 | 1 | 0 | 0 | 1 | 1 |
| Other non-operating income (expense) | (0) | (0) | (3) | (1) | (0) | (1) | 2 | (0) | (1) | (0) |
| Income before taxes | (5) | (11) | – | – | – | – | 0 | (1) | (3) | (4) |
| Net income from continuing operations | – | – | – | (5) | (2) | (2) | – | – | – | – |
| Net income | (6) | (11) | (12) | (5) | (3) | (2) | (0) | (1) | (3) | (4) |
| Net income to common shareholders | – | – | – | – | – | (2) | (0) | (1) | (3) | (4) |